tudy using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults

More than four years on since the start of the Covid-19 pandemic, this paper provides an assessment of reforms implemented at EU level to enhance the EU’s preparedness and response to future health threats.

Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.

Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.

Uptake of COVID-19 vaccines among pregnant individuals was hampered by safety concerns around potential risks to unborn children.

COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant.

People living in the United States are more likely to report that their government handled the COVID-19 pandemic ‘well’ than any other G7 nation despite having the highest death rate, according to a new report from the Global Listening Project.

Latest information about circulation, impact and what is needed to prevent infections, severe disease, post-COVID-19 condition and deaths.

Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass.

Bivalent mRNA COVID-19 vaccines were recommended in the US for children and adolescents aged 12 years or older on September 1, 2022, and for children aged 5 to 11 years on October 12, 2022.

Nearly 20 million people aged 60 years and above received COVID-19 vaccines during the autumn/winter campaign in the EU/EEA, according to a new report from the European Centre for Disease Prevention and Control (ECDC).